These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 16757381)
1. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381 [TBL] [Abstract][Full Text] [Related]
2. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. Gillespie RF; Gudas LJ J Mol Biol; 2007 Sep; 372(2):298-316. PubMed ID: 17663992 [TBL] [Abstract][Full Text] [Related]
6. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Zhao S; Venkatasubbarao K; Li S; Freeman JW Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289 [TBL] [Abstract][Full Text] [Related]
8. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279 [TBL] [Abstract][Full Text] [Related]
9. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. Qi H; Ratnam M Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727 [TBL] [Abstract][Full Text] [Related]
10. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655 [TBL] [Abstract][Full Text] [Related]
11. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. Minucci S; Horn V; Bhattacharyya N; Russanova V; Ogryzko VV; Gabriele L; Howard BH; Ozato K Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11295-300. PubMed ID: 9326603 [TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854 [TBL] [Abstract][Full Text] [Related]
16. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780 [TBL] [Abstract][Full Text] [Related]
17. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
18. Retinoic acid and retinaldehyde dehydrogenase are not involved in the specific induction of the follicle-stimulating hormone β subunit by trichostatin A, a selective inhibitor of histone deacetylase. Mijiddorj T; Kanasaki H; Sukhbaatar U; Oride A; Ishihara T; Kyo S Gen Comp Endocrinol; 2017 Feb; 242():59-65. PubMed ID: 26654743 [TBL] [Abstract][Full Text] [Related]